Business
Mativ Announces First Quarter 2025 Results
ALPHARETTA, Ga., May 07, 2025--Mativ Holdings, Inc. ("Mativ" or the "Company") (NYSE: MATV) reported earnings results for the three months ended March 31, 2025.
About this update from Mativ Holdings, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":246,"url":"https://media.zenfs.com/en/business-wire.com/a746ee44f09fa83bf21046080650a52f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Qg5tBybxO2Fny5eLL0aHVA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ5MjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/a746ee44f09fa83bf21046080650a52f","width":480,"height":246}},"lazy":false},{"type":"text","content":"ALPHARETTA, Ga., May 07, 2025--(BUSINESS WIRE)--Mativ Holdings, Inc. ("Mativ" or the "Company") (NYSE: MATV) reported earnings results for the three months ended March 31, 2025.","length":197,"tagName":"p"},{"type":"text","content":"Adjusted measures are reconciled to GAAP at the end of this release. Financial comparisons are versus the prior year period unless stated otherwise. Figures may not sum to total due to rounding.","length":194,"tagName":"p"},{"type":"text","content":"Mativ First Quarter 2025 Highlights","length":35,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Sales of $484.8 million decreased 3.1% year over year, and 0.2% on an organic basis","length":83,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":83,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"GAAP loss was $425.5 million, GAAP EPS was $(7.82); Results included a non-cash goodwill impairment charge of $411.9 million ($7.57 per share) as well as $14.5 million of organizational realignment and asset impairment expenses","length":227,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":227,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Adjusted EBITDA was $37.2 million, Adjusted loss was $6.0 million, and Adjusted EPS was $(0.14), (see non-GAAP reconciliations). Adjusted EBITDA was down 19% versus the prior year, as lower SG&A expenses across both segments and higher volume/mix in our SAS segment were more than offset by higher manufacturing and distribution costs, unfavorable net selling price versus input cost performance, and lower volume/mix in our FAM segment.","length":441,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":441,"olType":false},{"type":"text","content":"Management Comment...